Antibody-mediated impairment and homeostatic plasticity of autonomic ganglionic synaptic transmission

Experimental Neurology

Volumn 222, Issue 1, 2010, Pages 114-119

  Wang, Zhengbei ^a   Low, Phillip A ^b   Vernino, Steven ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Autoimmune; Electrophysiology; EPSP; Mouse; Passive transfer; Superior cervical ganglia

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; IMMUNOGLOBULIN G;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTONOMIC GANGLIONOPATHY; AUTONOMIC NEUROPATHY; BLOOD SAMPLING; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; HUMAN; IMMUNE RESPONSE; IN VITRO STUDY; MALE; MOUSE; NERVE CELL PLASTICITY; PATHOPHYSIOLOGY; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; SUPERIOR CERVICAL GANGLION;

ADULT; ANIMALS; AUTONOMIC NERVOUS SYSTEM DISEASES; ELECTRIC STIMULATION; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GANGLIA, AUTONOMIC; HUMANS; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NEURONAL PLASTICITY; NEURONS; RECEPTORS, NICOTINIC; SUPERIOR CERVICAL GANGLION; TIME FACTORS; YOUNG ADULT;

EID: 77649342111     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.12.016     Document Type: Article

References (24)

1. Alkadhi K.A., Salgado-Commissariat D., Hogan Y.H., Akpaudo S.B. Induction and maintenance of ganglionic long-term potentiation require activation of 5-hydroxytryptamine (5-HT3) receptors. J. Physiol. 1996, 496:479-489.
2. Briggs C.A., Brown T.H., McAfee D.A. Neurophysiology and pharmacology of long-term potentiation in the rat sympathetic ganglion. J. Physiol. 1985, 359:503-521.
3. Brown D.A., Fumagalli L. Dissociation of [alpha]-bungarotoxin binding and receptor block in the rat superior cervical ganglion. Brain Res. 1977, 129:165-168.
4. Clements J.D., Bekkers J.M. Detection of spontaneous synaptic events with an optimally scaled template. Biophys. J. 1997, 73:220-229.
5. Davis G.W., Goodman C.S. Synapse-specific control of synaptic efficacy at the terminals of a single neuron. Nature 1998, 392:82-86.
6. Gibbins I.L., Jobling P., Messenger J.P., Teo E.H., Morris J.L. Neuronal morphology and the synaptic organisation of sympathetic ganglia. J. Auton. Nerv. Syst. 2000, 81:104-109.
7. Gibbins I.L., Morris J.L. Structure of peripheral synapses: autonomic ganglia. Cell Tissue Res. 2006, 326:205-220.
8. Gibbons C.H., Vernino S.A., Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch. Neurol. 2008, 65:213-217.
9. Klein C.M., Vernino S., Lennon V.A., Sandroni P., Fealey R.D., Benrud-Larson L., Sletten D., Low P.A. The spectrum of autoimmune autonomic neuropathies. Ann. Neurol. 2003, 53:752-758.
10. Lennon V.A., Ermilov L.G., Szurszewski J.H., Vernino S. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J. Clin. Invest. 2003, 111:907-913.
11. McLachlan E.M., Davies P.J., Habler H.J., Jamieson J. On-going and reflex synaptic events in rat superior cervical ganglion cells. J. Physiol. 1997, 501:165-181.
12. Sandrock A.W., Dryer S.E., Rosen K.M., Gozani S.N., Kramer R., Theill L.E., Fischbach G.D. Maintenance of acetylcholine receptor number by neuregulins at the neuromuscular junction in vivo. Science 1997, 276:599-603.
13. Sandroni P., Vernino S., Klein C.M., Lennon V.A., Benrud-Larson L., Sletten D., Low P.A. Idiopathic autonomic neuropathy: comparison of cases seropositive and seronegative for ganglionic acetylcholine receptor antibody. Arch. Neurol. 2004, 61:44-48.
14. Schroeder C., Vernino S., Birkenfeld A.L., Tank J., Heusser K., Lipp A., Benter T., Lindschau C., Kettritz R., Luft F.C., Jordan J. Plasma exchange for primary autoimmune autonomic failure. N. Engl. J. Med. 2005, 353:1585-1590.
15. Skok M.V., Voitenko L.P., Voitenko S.V., Lykhmus E.Y., Kalashnik E.N., Litvin T.I., Tzartos S.J., Skok V.I. Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha(181-192) peptide antibodies. Neuroscience 1999, 93:1427-1436.
16. Suarez G.A., Fealey R.D., Camilleri M., Low P.A. Idiopathic autonomic neuropathy: Clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology 1994, 44:1675-1682.
17. Turrigiano G.G., Leslie K.R., Desai N.S., Rutherford L.C., Nelson S.B. Activity-dependent scaling of quantal amplitude in neocortical neurons. Nature 1998, 391:892-896.
18. Vautrin J., Kriebel M.E., Holsapple J. Further evidence for the dynamic formation of transmitter quanta at the neuromuscular junction. J. Neurosci. Res. 1992, 32:245-254.
19. Vernino S., Low P.A., Fealey R.D., Stewart J.D., Farrugia G., Lennon V.A. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N. Eng. J. Med. 2000, 343:847-855.
20. Vernino S., Low P.A., Lennon V.A. Experimental autoimmune autonomic neuropathy. J. Neurophysiol. 2003, 90:2053-2059.
21. Vernino S., Ermilov L.G., Sha L., Szurszewski J.H., Low P.A., Lennon V.A. Passive transfer of autoimmune autonomic neuropathy to mice. J. Neurosci. 2004, 24:7037-7042.
22. Vernino S., Lindstrom J., Hopkins S., Wang Z., Low P.A. Characterization of ganglionic acetylcholine receptor autoantibodies. J. Neuroimmunol. 2008, 197:63-69.
23. Wang Z., Low P.A., Jordan J., Freeman R., Gibbons C.H., Schroeder C., Sandroni P., Vernino S. Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology 2007, 68:1917-1921.
24. Xu W., Gelber S., Orr-Urtreger A., Armstrong D., Lewis R.A., Ou C.N., Patrick J., Role L., De Biasi M., Beaudet A.L. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:5746-5751.